Gliclazide Actavis

Gliclazide Actavis is an oral medication used to manage type 2 diabetes by helping to control blood sugar levels. This effective treatment is part of the sulfonylurea class of drugs and is designed to support diabetes management.

Gliclazide Actavis is primarily used for the treatment of type 2 diabetes mellitus. It works by stimulating the pancreas to produce more insulin, which helps to lower blood sugar levels. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise. Gliclazide Actavis is not suitable for type 1 diabetes or diabetic ketoacidosis.

Common effects of Gliclazide Actavis may include hypoglycemia, or low blood sugar, which can cause symptoms such as sweating, dizziness, and confusion. Other possible effects include nausea, vomiting, and stomach pain. It is important to monitor blood sugar levels regularly while taking this medication to avoid severe hypoglycemia.

Gliclazide Actavis should be used with caution in patients with liver or kidney disease, as these conditions can affect how the body processes the medication. It is also important to inform your healthcare provider about any other medical conditions or allergies before starting this treatment. Regular monitoring of blood sugar levels is essential to ensure the medication is working effectively and safely.

Gliclazide Actavis may interact with other medications, including certain antibiotics, antifungal drugs, and other diabetes medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be limited while taking Gliclazide Actavis, as it can increase the risk of hypoglycemia.